Alpha‐methylacyl‐CoA racemase: a multi‐institutional study of a new prostate cancer marker
Z. Jiang(University of Massachusetts Chan Medical School), Ximing J. Yang(Shenyang Aerospace University), Robert Blute(Harvard University), Chin‐Lee Wu(Massachusetts General Hospital), Jiangchun Xu(Pfizer (United States)), Kenneth L. Rock(Harvard University), Mahul B. Amin(Ontario Institute for Cancer Research), Charles B. Brendler(Johns Hopkins University), Robert H. Young(George Washington University Hospital), Bruce A. Woda(University of Massachusetts Chan Medical School), Lawrence M. Weiss(NeoGenomics (United States)), Thomas Krausz(University of Chicago), Maria Tretiakova(University of Washington), P Chu(City Of Hope National Medical Center), Kenneth A. Iczkowski(University of California, Davis)
Cited by 138
Related Papers
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
|Nature|2010|4k
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
|Nature Genetics|2014|1.1k
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
|Frontiers in Immunology|2021|1k